Board of Directors

About

The board of directors at Turnstone Biologics has a long history of experience in the field of biotechnology. Members have served on the boards of directors and compensation committees of various companies, including ACELYRIN, INC., Xenon Pharmaceuticals Inc., and Principia Biopharma. They have also served as chairmen of the audit committee for Turning Point Therapeutics and Fulcrum Therapeutics. Other experience includes being a director at HemoShear Therapeutics and Epizyme, as well as being a member of the board and compensation committee at HTG Molecular Diagnostics. In addition, members have also served on the scientific advisory boards of Tyligand Biosciences, Remedy Plan Therapeutics, and Oncorus. The board of directors at Turnstone Biologics is highly educated, with members holding degrees from Spring Arbor University, The Johns Hopkins University School of Medicine, University of California, San Diego, and Harvard Medical School.